Patrys Ltd. completed an upsized, oversubscribed placement of shares, raising A$4.6 million before costs.
Proceeds will go toward developing Patrys' Deoxymab platform and corporate activities, including insurance claim prosecution.
Somers and Partners Pty. Ltd. acted as lead manager for the placement.
Melbourne, Australia-based Patrys develops cancer therapies.
